Back

Gba1 Mutations Alter The Phenotype And Behaviour Of Dopaminergic Neurons In Parkinson Disease, Influencing Vglut2 And Cryab Expression

Rodriguez-Traver, E.; Suarez, L. M.; Crespo, C.; Gonzalez-Burgos, I.; Vecino, R.; Jurado-Coronel, J. C.; Galan, M.; Gonzalez-Gonzalez, M.; Moratalla, R.; Vicario, C.

2024-08-07 neuroscience
10.1101/2024.08.05.606574 bioRxiv
Show abstract

Mutations in the GBA1 gene are major risk factors for Parkinso[n]s disease (PD), but their role in PD pathology is not fully understood. The impact of GBA1 mutations was investigated in dopamine (DA) neurons obtained from induced pluripotent stem cells (iPSCs) derived from PD patients carrying the N370S or L444P GBA1 mutation. DA neurons co-expressing TH and VGLUT2 were detected in the cultures, and their number and/or expression of VGLUT2/SLC17A6 mRNA was markedly reduced in both N370S and L444P cultures compared to controls. A significant increase in the firing rate of N370S neurons was found, whereas evoked dopamine release was stronger from neurons carrying either mutation. Furthermore, mutant neurons accumulated abundant degenerative structures, and there was a significant accumulation of -synuclein aggregates in N370S neurons. Notably, a significant upregulation of the chaperone CRYAB/HSPB5/alpha-crystallin-B was found early in DA neuron differentiation and in the substantia nigra of PD patients. Our findings indicate that N370S and L444P GBA1 mutations impair midbrain DA neurons expressing VGLUT2, and provoke molecular, functional and structural changes, possibly involved in PD pathology.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.